Clearpoint Neuro is trading 27.86% down at $11.04 in pre-market, based on the supplied pre-market price, after closing at $15.31 on September 28; no reported company-specific announcement or overnight catalyst explains the decline.
- The company’s investor-relations press release page lists August 3 as its latest release, with no September 28 or September 29 announcement shown.
- Broader market conditions are mixed, and the available evidence does not establish a market-wide explanation for the move.